Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Tamoxifen MeSH Descriptor Data 2025


MeSH Heading
Tamoxifen
Tree Number(s)
D02.455.426.559.389.150.700.900
Unique ID
D013629
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D013629
Scope Note
One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.
Entry Term(s)
ICI-46,474
ICI-46474
ICI-47699
Nolvadex
Novaldex
Soltamox
Tamoxifen Citrate
Tomaxithen
Zitazonium
Pharm Action
Estrogen Antagonists
Antineoplastic Agents, Hormonal
Selective Estrogen Receptor Modulators
Bone Density Conservation Agents
Registry Numbers
094ZI81Y45
0
7FRV7310N6
Related Numbers
10540-29-1
54965-24-1
7FRV7310N6
CAS Type 1 Name
Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-
Previous Indexing
Dimethylamines (1973-1974)
Phenyl Ethers (1974)
Stilbenes (1966-1974)
Public MeSH Note
78; was see under STILBENES 1975-77
History Note
78(75); was see under STILBENES 1975-77
Date Established
1978/01/01
Date of Entry
1974/11/11
Revision Date
2016/07/01
Tamoxifen Preferred
Zitazonium Narrower
ICI-46474 Narrower
ICI-47699 Narrower
Tomaxithen Narrower
Tamoxifen Citrate Narrower
Nolvadex Narrower
Soltamox Narrower
page delivered in 0.127s